The diet-heart idea is kept alive by selective citation
He
et al maintain that saturated fat is bad and polyunsaturated fat is good for the
cardiovascular system.1 They reject a large number of contradictory
epidemiologic and experimental studies2 by the argument that they are
inconsistent and inadequate. Instead they refer to a previous study from their
group.3 In that study the authors had calculated that a replacement
of 5% of energy from saturated fatwith the same amount of
polyunsaturated fat should be followed by a 50% lower risk of coronary heart
disease. They claimed that this calculation was supported by Sacks and Katan’s
review4 of four allegedly successful dietary trials.5-8
However, these authors had ignored four similar trials with a less favourable
outcome.9-12
Relevant
data from all eight trials are shown in the table (see below). As seen, the
accumulated relative risk of death in the four trials cited by Sacks and Katan
decreased by eight percent, but in the four trials that they had ignored, it
increased by nine percent, and the figures for coronary mortality was not much
better.2,13Another
contradictory finding was that complicated atherosclerosis was significantly
more pronounced in the treatment group of the only trial that included a
post-mortem.8
This
way of reviewing the literature is not unique. In a meta-analysis of all
controlled, randomised cholesterol lowering trials I found that trials
considered supportive were cited on average 40 times, but unsupportive trials
only seven times per year.14 Also,
in three of the most influential American reviews of the diet-heart idea, half
of a large selection of contradictory studies were ignored; the rest were quoted irrelevantly; or insignificant findings in favour of
the hypothesis were inflated; or unsupportive results were quoted as if they
were supportive.15 And in a recent letter in Science Scott Grundy,
one of the main figures in the cholesterol campaign, claimed that saturated
fatty acids are the main dietary cause of coronary heart disease, but the many
studies he used as support either had not addressed this question, or they were
inconclusive, or directly contradictory.16
No
statistical operations are able to explain away the fact that an exchange of
saturated with polyunsaturated fats has no effect on mortality. This is also in
accordance with the findings of He et al. that intake of dietary fats are not
associated with the risk of stroke,17 and this is also what we should
expect because the idea that atherosclerosis in the coronary arteries should
have a different cause than atherosclerosis in the cerebral ones are highly
unlikely.
References
He
K, Willett WC, Ascherio A. Dietary fat intake and risk of stroke. Authors'
reply. BMJ 2003;327:1348-1349 [Full
text].
Ravnskov
U. The questionable role of saturated and polyunsaturated fatty acids in
cardiovascular disease. J
Clin Epidemiol
1998;51: 443-60. [CrossRef][ISI][Medline]
Hu
FB, Manson JE, Willett WC. Types
of dietary fat and risk of coronary heart disease: a critical review. J
Am Coll Nutr 2001;20: 5-19.[Abstract/Free
Full Text]
Sacks
FM, Katan M. Randomized clinical trials on the effects of dietary fat and
carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med
2002;113(suppl 9B): s13-24.[CrossRef]
Turpeinen
O, Karvonen MJ, Pekkarinen M, Miettinen M, Elosuo R, Paavilainen E. Dietary
prevention of coronary heart disease: The Finnish mental hospital study. Int
J Epidemiol 1979;8:99-118.
Leren
P. The effect of plasma cholesterol lowering diet in male survivors of
myocardial infection. A controlled clinical trial. Acta Med Scand
1966;(Suppl 466):1-92.
Research
committee to the Medical Research Council. Controlled trial of soya-bean oil
in myocardial infarction. Lancet 1968;2: 693-700.
Dayton S, Pearce ML, Hashimoto S, Dixon WJ, Tomiyasu U. A controlled trial
of a diet high in unsaturated fat in preventing complications of
atherosclerosis.Circulation 1969;40(suppl 2):1-63.
Woodhill
JM, Palmer AJ, Leelarthaepin B, McGilchrist C, Blacket RB. Low fat, low
cholesterol diet in secondary prevention of coronary heart disease. Adv
Exp Med Biol 1978;109:317-330.
Frantz
ID Jr, Dawson EA, Ashman PL, Gatewood LC, Bartsch GE, Kuba K, Brewer ER. Test
of effect of lipid lowering by diet on cardiovascular risk. The Minnesota
Coronary Survey. Arteriosclerosis. 1989;9:129-35.
Rose
GA, Thomson WB, Williams RT. Corn oil in treatment of ischaemic heart
disease. BMJ 1965;544:1531-3.
Burr
ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC,
Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and
myocardial reinfarction: diet and reinfarction trial (DART). Lancet.
1989;2:757-61.
Hooper
L, Summerbell CD, Higgins JPT, Thompson R, Capps NE, Davey Smith G, et al.
Dietary fat intake and prevention of cardiovascular disease: systematic
review. BMJ 2001; 322: 757-763[Abstract/Free
Full Text].
Ravnskov
U. Cholesterol lowering trials in coronary
heart disease: frequency of citation and outcome. BMJ 1992;305: 15-19. [Abstract]
Ravnskov
U. Quotation bias in reviews of the diet-heart idea. J
Clin Epidemiol
1995; 48: 713-9. [Abstract]
Ravnskov
U, Allan C, Atrens D, Enig MG, Groves B, Kaufman J, Kroneld R, Rosch PJ,
Rosenman R, Werkö L, Nielsen JV, Wilske J, Worm N.Studies
of dietary fat and heart disease. Science 2002; 295:1464-1465.
He
K, Merchant A, Rimm EB, Rosner BA, Stampfer MJ, Willett WC, Ascherio
A. Dietary fat intake and risk of stroke in male US healthcare professionals:
14 year prospective cohort study. BMJ 2003 327: 777-782.[Abstract][Abridged
text][Full
text]
Table. Total
mortality in eight cholesterol-lowering, controlled and randomised dietary
trials, where the only intervention was an exchange of saturated fats with
polyunsaturated fats.
Patients
(n)
T/C
SFA
(cal%)
T/C
PUFA
(cal%)
T/C
All
deaths
(n)
T/C
All
deaths
(%)
T/C
Relative
risk
(%)
Absolute
risk
(%)
Trials
cited by Sacks and Katan4
Finnish
Mental Hospital*5
1. period
2. period
248/213
196/265
No data
No data
No data
No data
4/7
2/5
1.6/3.3
1.0/1.9
-52
-47
-1.7
-0.9
Oslo6
206/206
8.8/
?
20.7/
?
41/56
19.9/27.2
-27
-7.3
MRC
soy oil7
199/194
No
data
No
data
28/31
14/16
-12
-1.9
Los
Angeles8
424/422
8.3/18.5
16.1/4.1
174/177
41.0/41.9
-2
-0.9
Total
1273/1300
249/276
19.6/21.2
-8
-1.7
Trials
ignored by Sacks and Katan4
Sydney
Diet Heart9
221/237
9.8/13.5
15.1/8.9
39/28
17.6/11.8
+49
+5.8
Minnesota10
men
women
2197/2196
2344/2320
9.2/18.3
9.2/18.3
14.7/5.2
14.7/5.2
158/153
111/95
7.2/7.0
4.7/4.1
+3
+16
+0.2
+0.6
London11
Olive oil
Corn oil
26/26
28/**
No data
No data
No data
No data
3/1
5/**
11.5/3.8**
17.9/3.8**
+200
+365
+7.7
+14.0
DART12
1018/1015
11/15
9/7
111/113
10.9/11.1
-2
-0.2
Total
5834/5794
427/390
7.3/6.7
+9
+0.6
Grand
total
7107/7094
676/666
9.5/9.4
+1
+0.1
*:
Not randomised
**: Only one control group
SFA: Saturated fatty acids
PUFA: Polyunsaturated fatty acids
Cal%:
Calories from fats in per cent of total calories
Rapid Response:
The diet-heart idea is kept alive by selective citation
He
et al maintain that saturated fat is bad and polyunsaturated fat is good for the
cardiovascular system.1 They reject a large number of contradictory
epidemiologic and experimental studies2 by the argument that they are
inconsistent and inadequate. Instead they refer to a previous study from their
group.3 In that study the authors had calculated that a replacement
of 5% of energy from saturated fatwith the same amount of
polyunsaturated fat should be followed by a 50% lower risk of coronary heart
disease. They claimed that this calculation was supported by Sacks and Katan’s
review4 of four allegedly successful dietary trials.5-8
However, these authors had ignored four similar trials with a less favourable
outcome.9-12
Relevant
data from all eight trials are shown in the table (see below). As seen, the
accumulated relative risk of death in the four trials cited by Sacks and Katan
decreased by eight percent, but in the four trials that they had ignored, it
increased by nine percent, and the figures for coronary mortality was not much
better.2,13 Another
contradictory finding was that complicated atherosclerosis was significantly
more pronounced in the treatment group of the only trial that included a
post-mortem.8
This
way of reviewing the literature is not unique. In a meta-analysis of all
controlled, randomised cholesterol lowering trials I found that trials
considered supportive were cited on average 40 times, but unsupportive trials
only seven times per year.14 Also,
in three of the most influential American reviews of the diet-heart idea, half
of a large selection of contradictory studies were ignored;
the rest were quoted irrelevantly; or insignificant findings in favour of
the hypothesis were inflated; or unsupportive results were quoted as if they
were supportive.15 And in a recent letter in Science Scott Grundy,
one of the main figures in the cholesterol campaign, claimed that saturated
fatty acids are the main dietary cause of coronary heart disease, but the many
studies he used as support either had not addressed this question, or they were
inconclusive, or directly contradictory.16
No
statistical operations are able to explain away the fact that an exchange of
saturated with polyunsaturated fats has no effect on mortality. This is also in
accordance with the findings of He et al. that intake of dietary fats are not
associated with the risk of stroke,17 and this is also what we should
expect because the idea that atherosclerosis in the coronary arteries should
have a different cause than atherosclerosis in the cerebral ones are highly
unlikely.
References
K, Willett WC, Ascherio A. Dietary fat intake and risk of stroke. Authors'
reply. BMJ 2003;327:1348-1349 [Full
text].
U. The questionable role of saturated and polyunsaturated fatty acids in
cardiovascular disease. J
Clin Epidemiol
1998;51: 443-60. [CrossRef][ISI][Medline]
FB, Manson JE, Willett WC. Types
of dietary fat and risk of coronary heart disease: a critical review. J
Am Coll Nutr 2001;20: 5-19.[Abstract/Free
Full Text]
FM, Katan M. Randomized clinical trials on the effects of dietary fat and
carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med
2002;113(suppl 9B): s13-24.[CrossRef]
O, Karvonen MJ, Pekkarinen M, Miettinen M, Elosuo R, Paavilainen E. Dietary
prevention of coronary heart disease: The Finnish mental hospital study. Int
J Epidemiol 1979;8:99-118.
P. The effect of plasma cholesterol lowering diet in male survivors of
myocardial infection. A controlled clinical trial. Acta Med Scand
1966;(Suppl 466):1-92.
committee to the Medical Research Council. Controlled trial of soya-bean oil
in myocardial infarction. Lancet 1968;2: 693-700.
S, Pearce ML, Hashimoto S, Dixon WJ, Tomiyasu U. A controlled trial
of a diet high in unsaturated fat in preventing complications of
atherosclerosis. Circulation 1969;40(suppl 2):1-63.
JM, Palmer AJ, Leelarthaepin B, McGilchrist C, Blacket RB. Low fat, low
cholesterol diet in secondary prevention of coronary heart disease. Adv
Exp Med Biol 1978;109:317-330.
ID Jr, Dawson EA, Ashman PL, Gatewood LC, Bartsch GE, Kuba K, Brewer ER. Test
of effect of lipid lowering by diet on cardiovascular risk. The Minnesota
Coronary Survey. Arteriosclerosis. 1989;9:129-35.
GA, Thomson WB, Williams RT. Corn oil in treatment of ischaemic heart
disease. BMJ 1965;544:1531-3.
ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC,
Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and
myocardial reinfarction: diet and reinfarction trial (DART). Lancet.
1989;2:757-61.
L, Summerbell CD, Higgins JPT, Thompson R, Capps NE, Davey Smith G, et al.
Dietary fat intake and prevention of cardiovascular disease: systematic
review. BMJ 2001; 322: 757-763[Abstract/Free
Full Text].
U. Cholesterol lowering trials in coronary
heart disease: frequency of citation and outcome. BMJ 1992;305: 15-19. [Abstract]
U. Quotation bias in reviews of the diet-heart idea. J
Clin Epidemiol
1995; 48: 713-9. [Abstract]
U, Allan C, Atrens D, Enig MG, Groves B, Kaufman J, Kroneld R, Rosch PJ,
Rosenman R, Werkö L, Nielsen JV, Wilske J, Worm N.Studies
of dietary fat and heart disease. Science 2002; 295:1464-1465.
K, Merchant A, Rimm EB, Rosner BA, Stampfer MJ, Willett WC, Ascherio
A. Dietary fat intake and risk of stroke in male US healthcare professionals:
14 year prospective cohort study. BMJ 2003 327: 777-782.
text][Full
text]
Table.
Total
mortality in eight cholesterol-lowering, controlled and randomised dietary
trials, where the only intervention was an exchange of saturated fats with
polyunsaturated fats.
Patients
(n)
T/C
SFA
(cal%)
T/C
PUFA
(cal%)
T/C
All
deaths
(n)
T/C
All
deaths
(%)
T/C
Relative
risk
(%)
Absolute
risk
(%)
Trials
cited by Sacks and Katan4
Finnish
Mental Hospital*5
1. period
2. period
248/213
196/265
No data
No data
No data
No data
4/7
2/5
1.6/3.3
1.0/1.9
-52
-47
-1.7
-0.9
Oslo6
206/206
8.8/
?
20.7/
?
41/56
19.9/27.2
-27
-7.3
MRC
soy oil7
199/194
No
data
No
data
28/31
14/16
-12
-1.9
Los
Angeles8
424/422
8.3/18.5
16.1/4.1
174/177
41.0/41.9
-2
-0.9
Total
1273/1300
249/276
19.6/21.2
-8
-1.7
Trials
ignored by Sacks and Katan4
Sydney
Diet Heart9
221/237
9.8/13.5
15.1/8.9
39/28
17.6/11.8
+49
+5.8
Minnesota10
men
women
2197/2196
2344/2320
9.2/18.3
9.2/18.3
14.7/5.2
14.7/5.2
158/153
111/95
7.2/7.0
4.7/4.1
+3
+16
+0.2
+0.6
London11
Olive oil
Corn oil
26/26
28/**
No data
No data
No data
No data
3/1
5/**
11.5/3.8**
17.9/3.8**
+200
+365
+7.7
+14.0
DART12
1018/1015
11/15
9/7
111/113
10.9/11.1
-2
-0.2
Total
5834/5794
427/390
7.3/6.7
+9
+0.6
Grand
total
7107/7094
676/666
9.5/9.4
+1
+0.1
*:
Not randomised
**: Only one control group
SFA: Saturated fatty acids
PUFA: Polyunsaturated fatty acids
Cal%:
Calories from fats in per cent of total calories
n: number
T: Treatment group
C: Control group
Competing interests:
None declared
Competing interests: No competing interests